According to Regencell Bioscience Holdings latest financial reports the total debt is $25.41K, an decrease of -92.95% to 2022. At the end of 2022 company had $360.27K total debt. This figure represents the debts and financial obligations that Regencell Bioscience Holdings combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $25.41K | -92.95% |
2022 | $360.27K | Infinity% |
2021 | $0 | - |